Bullfrog AI Holdings, Inc. Common Stock
BFRGBullfrog AI Holdings, Inc. is a technology company focused on developing artificial intelligence solutions, particularly for automation and data analysis. The company aims to leverage AI technologies to enhance operational efficiencies across various industries.
Company News
BullFrog AI Holdings, Inc. (NASDAQ: BFRG) announced the launch of bfARENAS™, a scenario-based decision engine designed to help biotech and pharmaceutical companies optimize drug portfolio strategy and clinical trial design. The new tool completes the company's end-to-end AI intelligence workflow by enabling head-to-head comparison of drug progr...
ProFound Therapeutics appointed Tom Chittenden as Chief Technology Officer and Laurel Ostrom as Chief Human Resources Officer to enhance their AI-driven drug discovery platform and organizational capabilities.
BullFrog AI, a technology-enabled drug development company, announced a strategic collaboration with Sygnature Discovery, a UK-based contract research organization. Through this collaboration, Sygnature will introduce BullFrog's AI-driven data insights platform, BullFrog Data Networks™, to its global biopharma client base.
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on...
GAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the availability o...
